The Manufacturers Life Insurance Company lifted its stake in LifePoint Health Inc (NASDAQ:LPNT) by 11.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 65,248 shares of the company’s stock after acquiring an additional 6,504 shares during the quarter. The Manufacturers Life Insurance Company owned 0.17% of LifePoint Health worth $3,249,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the company. Wells Fargo & Company MN lifted its holdings in shares of LifePoint Health by 121.0% in the 4th quarter. Wells Fargo & Company MN now owns 79,235 shares of the company’s stock worth $3,946,000 after acquiring an additional 43,385 shares during the last quarter. First Trust Advisors LP lifted its holdings in shares of LifePoint Health by 33.4% in the 4th quarter. First Trust Advisors LP now owns 414,248 shares of the company’s stock worth $20,630,000 after acquiring an additional 103,680 shares during the last quarter. New Mexico Educational Retirement Board acquired a new position in shares of LifePoint Health in the 4th quarter worth approximately $493,000. KBC Group NV lifted its holdings in shares of LifePoint Health by 252.1% in the 4th quarter. KBC Group NV now owns 47,209 shares of the company’s stock worth $2,351,000 after acquiring an additional 33,802 shares during the last quarter. Finally, California Public Employees Retirement System lifted its holdings in shares of LifePoint Health by 8.0% in the 4th quarter. California Public Employees Retirement System now owns 201,544 shares of the company’s stock worth $10,037,000 after acquiring an additional 14,855 shares during the last quarter.
Several brokerages recently weighed in on LPNT. Goldman Sachs Group began coverage on shares of LifePoint Health in a research note on Wednesday, January 3rd. They set a “sell” rating and a $45.00 target price on the stock. Leerink Swann downgraded shares of LifePoint Health from an “outperform” rating to a “market perform” rating and upped their target price for the stock from $46.30 to $58.00 in a research note on Monday, March 5th. BidaskClub raised shares of LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Wells Fargo & Co began coverage on shares of LifePoint Health in a research note on Tuesday, January 30th. They set a “market perform” rating and a $52.00 target price on the stock. Finally, BMO Capital Markets cut their target price on shares of LifePoint Health to $47.00 and set a “market perform” rating on the stock in a research note on Monday, February 26th. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $55.00.
LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.04). LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the previous year, the company posted $1.07 EPS. The company’s quarterly revenue was down 7.2% on a year-over-year basis. equities research analysts anticipate that LifePoint Health Inc will post 4.27 earnings per share for the current year.
In other LifePoint Health news, Chairman William F. Carpenter III purchased 21,368 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The stock was purchased at an average price of $46.80 per share, for a total transaction of $1,000,022.40. Following the purchase, the chairman now directly owns 482,668 shares in the company, valued at $22,588,862.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider David M. Dill sold 45,000 shares of the stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the sale, the insider now owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. Corporate insiders own 8.76% of the company’s stock.
TRADEMARK VIOLATION WARNING: “LifePoint Health Inc (LPNT) Stake Boosted by The Manufacturers Life Insurance Company” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/03/14/lifepoint-health-inc-lpnt-stake-boosted-by-the-manufacturers-life-insurance-company.html.
LifePoint Health Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health Inc (NASDAQ:LPNT).
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.